Lyn-Cook, L. E., Lawton, M., Tong, M., Silbermann, E., Longato, L., Jiao, P., . . . de la Monte, S. M. (2009). Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis.
Chicago-стиль цитированияLyn-Cook, Lascelles E., et al. Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis. 2009.
MLA-цитированиеLyn-Cook, Lascelles E., et al. Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis. 2009.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.